CytoTools Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | CytoTools AG

CytoTools AG | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

UBS AG (Investment Management)

14,000

0.7%

14,000

12/31/2017

AMF Capital AG

6,000

0.3%

0.56%

10/31/2017

Spirit Asset Management SA

3,500

0.18%

3,500

0.22%

12/31/2017

View Profile

Address	Klappacher Strasse 126 Darmstadt Hessen 64285 Germany
Employees	-
Website	http://cytotools.de
Updated	07/08/2019
CytoTools AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept.